Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.2250
+0.0150 (7.14%)
Sep 30, 2026, 5:15 PM GMT
Verici Dx Employees
Verici Dx had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Verici Dx the 38,516th largest employer in the world and 797th in the United Kingdom.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
115.41K GBP
Profits / Employee
-258.13K GBP
Market Cap
5.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | -1 | -6.67% |
| Dec 31, 2022 | 15 | 5 | 50.00% |
| Dec 31, 2021 | 10 | 2 | 25.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| GSK plc | 66,841 |
| Haleon | 24,535 |
| Smith & Nephew | 17,000 |
| Surgical Innovations Group | 82 |
| GENinCode | 44 |
| Proteome Sciences | 32 |
| OptiBiotix Health | 9 |
Verici Dx News
- 9 days ago - Verici Dx Quarterly report: H1 2026 - Filings
- 3 months ago - Verici Dx Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - Verici Dx Annual report: H2 2025 - Filings
- 3 months ago - Verici Dx Annual report: H2 2025 - Filings
- 3 months ago - Verici Dx Slides: H2 2025 - Filings
- 3 months ago - Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test - Business Wire
- 3 months ago - Verici Dx Collaborators to Present Data on Predictive Value of Tutivia™ for Acute Kidney Transplant Rejection at ATC 2026 - Business Wire
- 4 months ago - CORRECTING and REPLACING Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients - Business Wire